| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.905 | 0.002 | 0.905 | Alpha adrenoreceptor agonist | 0.189 0.01 CID_46781916 | ||
| 0.89 | 0.001 | 0.89 | Alpha 2 adrenoreceptor agonist | 0.206 0.004 CID_46781916 | ||
| 0.833 | 0 | 0.833 | Alpha 2a adrenoreceptor agonist | 0.342 0.002 CID_46781916 | ||
| 0.741 | 0.001 | 0.741 | Alpha 2c adrenoreceptor agonist | 0.053 0.003 CID_46781916 | ||
| 0.638 | 0.004 | 0.638 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.496 0.005 CID_46781916 | ||
| 0.599 | 0.003 | 0.599 | Alpha 1 adrenoreceptor agonist | 0.067 0.03 CID_46781916 | ||
| 0.571 | 0.002 | 0.571 | Prostacyclin antagonist | 0.065 0.008 CID_46781916 | ||
| 0.431 | 0.008 | 0.431 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.304 0.026 CID_46781916 | ||
| 0.402 | 0.008 | 0.402 | Antiadrenergic | |||
| 0.399 | 0.008 | 0.399 | Adrenaline antagonist | |||
| 0.397 | 0.006 | 0.397 | Protein kinase (CK1) gamma 3 inhibitor | 0.297 0.017 CID_46781916 | ||
| 0.369 | 0.004 | 0.369 | ALK inhibitor | 0.219 0.01 CID_46781916 | ||
| 0.368 | 0.009 | 0.368 | Protein kinase (CK1) gamma inhibitor | 0.244 0.031 CID_46781916 | ||
| 0.342 | 0.006 | 0.342 | Protein kinase (CK1) gamma 2 inhibitor | 0.253 0.02 CID_46781916 | ||
| 0.354 | 0.023 | 0.354 | EphB2 antagonist | 0.26 0.051 CID_46781916 | ||
| 0.346 | 0.02 | 0.346 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.21 0.062 CID_46781916 | ||
| 0.345 | 0.027 | 0.345 | Death-associated protein kinase 3 inhibitor | 0.202 0.073 CID_46781916 | ||
| 0.301 | 0.011 | 0.301 | Polo-like kinase-3 inhibitor | 0.197 0.047 CID_46781916 | ||
| 0.272 | 0.001 | 0.272 | Alpha 1a adrenoreceptor agonist | 0.099 0.003 CID_46781916 | ||
| 0.266 | 0.004 | 0.266 | Adrenaline agonist | 0.074 0.066 CID_46781916 | ||
| 0.25 | 0.004 | 0.25 | Thioredoxin reductase inhibitor | 0.212 0.004 CID_46781916 | ||
| 0.248 | 0.004 | 0.248 | Vitronectin receptor antagonist | |||
| 0.269 | 0.026 | 0.269 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.254 0.03 CID_46781916 | ||
| 0.294 | 0.052 | 0.294 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.152 0.129 CID_46781916 | ||
| 0.25 | 0.009 | 0.25 | Telomerase inhibitor | 0.129 0.024 CID_46781916 | ||
| 0.275 | 0.036 | 0.275 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.168 0.108 CID_46781916 | ||
| 0.267 | 0.029 | 0.267 | Focal adhesion kinase 2 inhibitor | 0.144 0.141 CID_46781916 | ||
| 0.293 | 0.055 | 0.293 | Dyrk kinase inhibitor | 0.145 0.141 CID_46781916 | ||
| 0.355 | 0.118 | 0.355 | Cyclophilin D inhibitor | |||
| 0.279 | 0.049 | 0.279 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.238 0.06 CID_46781916 | ||
| 0.231 | 0.005 | 0.231 | Thioredoxin inhibitor | 0.194 0.009 CID_46781916 | ||
| 0.257 | 0.033 | 0.267 | Protein kinase C nu inhibitor | 0.267 0.031 CID_46781916 | CID_46781916 | |
| 0.283 | 0.077 | 0.283 | Spasmolytic | |||
| 0.227 | 0.034 | 0.227 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.106 0.094 CID_46781916 | ||
| 0.209 | 0.016 | 0.209 | Alpha 2c adrenoreceptor antagonist | |||
| 0.181 | 0.004 | 0.181 | Acetylcholine M2 receptor agonist | 0.104 0.006 CID_46781916 | ||
| 0.231 | 0.055 | 0.231 | TRKC antagonist | |||
| 0.164 | 0.003 | 0.164 | Alpha 1b adrenoreceptor agonist | |||
| 0.246 | 0.085 | 0.246 | Cardiotonic | |||
| 0.191 | 0.034 | 0.191 | Cholinergic antagonist | |||
| 0.26 | 0.104 | 0.26 | Caspase 3 stimulant | 0.222 0.14 CID_46781916 | ||
| 0.193 | 0.038 | 0.193 | Bone formation stimulant | |||
| 0.265 | 0.113 | 0.265 | Angiogenesis inhibitor | |||
| 0.152 | 0.002 | 0.152 | Alpha 1L adrenoreceptor agonist | |||
| 0.209 | 0.062 | 0.209 | CDC-like kinase 2 inhibitor | |||
| 0.326 | 0.179 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.19 | 0.051 | 0.19 | Cholinergic | |||
| 0.162 | 0.034 | 0.162 | Alpha 2b adrenoreceptor antagonist | |||
| 0.151 | 0.027 | 0.151 | Alpha 2 adrenoreceptor antagonist | |||
| 0.128 | 0.004 | 0.128 | Integrin alphaVbeta3 antagonist | 0.022 0.015 CID_46781916 | ||
| 0.122 | 0.003 | 0.122 | Alpha 2d adrenoreceptor agonist | 0.021 0.016 CID_46781916 | ||
| 0.167 | 0.056 | 0.167 | Lck kinase inhibitor | |||
| 0.12 | 0.012 | 0.12 | NMDA 2B receptor antagonist | |||
| 0.165 | 0.062 | 0.165 | Acetylcholine M1 receptor antagonist | |||
| 0.253 | 0.152 | 0.253 | GABA C receptor rho-3 antagonist | |||
| 0.093 | 0.002 | 0.093 | Integrin beta6 antagonist | 0.024 0.004 CID_46781916 | ||
| 0.144 | 0.058 | 0.144 | Aurora-C kinase inhibitor | |||
| 0.128 | 0.046 | 0.128 | Protein kinase C gamma inhibitor | 0.113 0.058 CID_46781916 | ||
| 0.1 | 0.018 | 0.1 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.112 | 0.031 | 0.112 | Alpha 1b adrenoreceptor antagonist | |||
| 0.115 | 0.037 | 0.115 | Acetylcholine M3 receptor agonist | |||
| 0.079 | 0.004 | 0.079 | Integrin alphaVbeta1 antagonist | |||
| 0.081 | 0.007 | 0.081 | Potassium channel (Inward rectifier) activator | |||
| 0.079 | 0.007 | 0.079 | Potassium channel (ATP-sensitive) activator | |||
| 0.111 | 0.044 | 0.111 | DNA directed RNA polymerase inhibitor | 0.083 0.08 CID_46781916 | ||
| 0.069 | 0.003 | 0.069 | Imidazoline I1 receptor antagonist | |||
| 0.149 | 0.084 | 0.149 | Src kinase inhibitor | |||
| 0.101 | 0.036 | 0.101 | Alpha 2a adrenoreceptor antagonist | |||
| 0.108 | 0.044 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.074 CID_46781916 | ||
| 0.111 | 0.049 | 0.111 | Insulin receptor antagonist | |||
| 0.084 | 0.029 | 0.084 | Alpha 1d adrenoreceptor antagonist | |||
| 0.12 | 0.065 | 0.12 | 5 Hydroxytryptamine antagonist | |||
| 0.056 | 0.003 | 0.056 | Alpha 2b adrenoreceptor agonist | |||
| 0.129 | 0.078 | 0.129 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.08 | 0.035 | 0.08 | CDC7 inhibitor | |||
| 0.101 | 0.056 | 0.101 | Alpha adrenoreceptor antagonist | |||
| 0.148 | 0.111 | 0.148 | Catenin beta inhibitor | |||
| 0.042 | 0.006 | 0.042 | Integrin beta5 antagonist | |||
| 0.04 | 0.005 | 0.04 | Complement factor 1r inhibitor | 0.025 0.019 CID_46781916 | ||
| 0.075 | 0.041 | 0.075 | Transforming growth factor antagonist | |||
| 0.07 | 0.037 | 0.07 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.074 | 0.044 | 0.074 | Prostaglandin-E synthase inhibitor | |||
| 0.076 | 0.046 | 0.076 | NMDA 2 receptor antagonist | |||
| 0.174 | 0.144 | 0.174 | RNA-directed DNA polymerase inhibitor | 0.171 0.151 CID_46781916 | ||
| 0.103 | 0.074 | 0.103 | Polo-like kinase-4 inhibitor | |||
| 0.078 | 0.049 | 0.078 | Acetylcholine M4 receptor antagonist | |||
| 0.144 | 0.118 | 0.144 | Phospholipase C inhibitor | |||
| 0.098 | 0.078 | 0.098 | Protein kinase (CK2) alpha inhibitor | |||
| 0.04 | 0.029 | 0.04 | Integrin alpha5beta1 antagonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.087 | 0.079 | 0.087 | Alpha 2d adrenoreceptor antagonist | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.135 | 0.129 | 0.135 | Clk dual-specificity kinase inhibitor | |||
| 0.037 | 0.032 | 0.037 | Integrin antagonist | |||
| 0.019 | 0.014 | 0.019 | Integrin beta3 antagonist | |||
| 0.082 | 0.081 | 0.082 | Protein kinase (CK2) inhibitor | |||
| 0.041 | 0.082 | 0.063 | Glucosylceramidase inhibitor | 0.063 0.028 CID_46781916 | CID_46781916 | |
| 0.036 | 0.079 | 0.054 | CXC chemokine 1 receptor antagonist | 0.054 0.03 CID_46781916 | CID_46781916 | |
| 0.124 | 0.267 | 0.183 | DNA synthesis inhibitor | 0.183 0.149 CID_46781916 | CID_46781916 | |
| 0.02 | 0.342 | 0.115 | Protein kinase B beta inhibitor | 0.115 0.017 CID_46781916 | CID_46781916 | |
| 0.031 | 0.483 | 0.326 | Nav1.1 sodium channel blocker | 0.326 0.007 CID_46781916 | CID_46781916 | |
| 0.002 | 0.967 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 CID_46781916 | CID_46781916 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |